Overview

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
A multicenter study to compare multiple doses of intravitreal microplasmin in patients undergoing surgical vitrectomy.
Phase:
Phase 2
Details
Lead Sponsor:
ThromboGenics
Treatments:
Fibrinolysin
Plasminogen